These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The impact of obesity on reproduction in women with polycystic ovary syndrome. Pasquali R, Gambineri A, Pagotto U. BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825 [Abstract] [Full Text] [Related]
13. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Franks S, McCarthy MI, Hardy K. Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494 [Abstract] [Full Text] [Related]
14. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS. Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437 [Abstract] [Full Text] [Related]
15. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM. Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263 [Abstract] [Full Text] [Related]
16. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Wu J, Zhu Y, Jiang Y, Cao Y. Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522 [Abstract] [Full Text] [Related]
17. The role of low-grade inflammation in the polycystic ovary syndrome. Repaci A, Gambineri A, Pasquali R. Mol Cell Endocrinol; 2011 Mar 15; 335(1):30-41. PubMed ID: 20708064 [Abstract] [Full Text] [Related]